Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
If you're currently covered, you may receive notice of formulary changes before renewal
Gatta M, Dovizio M, Milillo C, Ruggieri AG, Sallese M, Antonucci I, et al
Drug rashes, or drug eruptions, are reactions your skin may develop in response to certain drugs
Pregnancy & Lactation Data are insufficient to establish safety
The pipeline continues to expand: Novo Nordisk filed an NDA for CagriSema (semaglutide + cagrilintide) in December 2025, which achieved 22.7% weight loss in the REDEFINE 1 trial, and Eli Lilly reported Phase 3 results for retatrutide , a triple GIP/GLP-1/glucagon agonist that delivered 28.7% weight loss
Should Anyone Avoid Taking Ozempic Due to GI Issues Like Diarrhea
US$ 23.62
US$ 21.57
US$ 25.05
US$ 23.19
US$ 29.43
US$ 20.85
US$ 25.47
US$ 29.32
